4.6 Article

Nonsteroidal Anti-Inflammatory Use and LRRK2 Parkinson's Disease Penetrance

期刊

MOVEMENT DISORDERS
卷 35, 期 10, 页码 1755-1764

出版社

WILEY
DOI: 10.1002/mds.28189

关键词

-

资金

  1. Michael J. Fox Foundation
  2. Smart Family Foundation
  3. National Institutes of Health/National Institute of Neurological Disorders and Stroke [K23NS0099441-O1A]
  4. Michael J. Fox Foundation for Parkinson's Research
  5. German Research Foundation (DFG) [FOR2488]

向作者/读者索取更多资源

Background The penetrance of leucine rich repeat kinase 2 (LRRK2) mutations is incomplete and may be influenced by environmental and/or other genetic factors. Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to reduce inflammation and may lower Parkinson's disease (PD) risk, but their role inLRRK2-associated PD is unknown. Objectives The objective of this study is to evaluate the association of regular NSAID use andLRRK2-associated PD. Methods Symptomatic (LRRK2-PD) and asymptomatic (LRRK2-non-PD) participants withLRRK2G2019S, R1441X, or I2020T variants (definitely pathogenic variant carriers) or G2385R or R1628P variants (risk variant carriers) from 2 international cohorts provided information on regular ibuprofen and/or aspirin use (>= 2 pills/week for >= 6 months) prior to the index date (diagnosis date for PD, interview date for non-PD). Multivariate logistic regression was used to evaluate the relationship between regular NSAID use and PD for any NSAID, separately for ibuprofen and aspirin in all carriers and separately in pathogenic and risk variant groups. Results A total of 259 LRRK2-PD and 318 LRRK2-non-PD participants were enrolled. Regular NSAID use was associated with reduced odds of PD in the overall cohort (odds ratio [OR], 0.34; 95% confidence interval [CI], 0.21-0.57) and in both pathogenic and risk variant carriers (ORPathogenic, 0.38; 95% CI, 0.21-0.67 and ORRiskVariant, 0.19; 95% CI, 0.04-0.99). Similar associations were observed for ibuprofen and aspirin separately (ORIbuprofen, 0.19; 95% CI, 0.07-0.50 and ORAspirin, 0.51; 95% CI, 0.28-0.91). Conclusions Regular NSAID use may be associated with reduced penetrance inLRRK2-associated PD. The LRRK2 protein is involved in inflammatory pathways and appears to be modulated by regular anti-inflammatory use. Longitudinal observational and interventional studies of NSAID exposure and LRRK2-PD are needed to confirm this association. (c) 2020 International Parkinson and Movement Disorder Society

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据